Incidence and Predictors of Left Ventricular Thrombus Formation After Acute Myocardial Infarction With ST-Segment

Devrim Kurt1, Emre Yılmaz1, Sencer Çamcı2

  • 1Cardiology, Giresun University Faculty of Medicine, Giresun, TUR.

Cureus
|January 15, 2024
PubMed

Insights

Left ventricular thrombus (LVT) occurs in 17.6% of patients after ST-segment elevation myocardial infarction (STEMI) despite primary percutaneous coronary intervention (PCI). Anterior STEMI, reduced ejection fraction, and wall motion score index (WMSI) are key risk factors.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • Left ventricular thrombus (LVT) is a potential complication following acute ST-segment elevation myocardial infarction (STEMI).
  • The incidence and risk factors of LVT in the era of primary percutaneous coronary intervention (PCI) require ongoing evaluation.

Purpose of the Study:

  • To determine the frequency and identify independent risk factors for LVT after acute STEMI.
  • To assess the diagnostic power of various electrocardiographic and echocardiographic parameters for LVT prediction.

Main Methods:

  • A prospective study of 131 patients with acute STEMI treated with primary PCI.
  • Transthoracic echocardiography (TTE) was used to detect LVT.
  • Analysis included electrocardiographic (Q waves, ST deviation, QT dispersion) and echocardiographic (ejection fraction, volumes, wall motion score index) parameters.

Main Results:

  • The incidence of LVT was 17.6%.
  • Anterior STEMI, higher wall motion score index (WMSI), increased pathological Q waves, aneurysm formation, and lower ejection fraction (EF) were significant risk factors for LVT.
  • WMSI demonstrated the highest diagnostic power for LVT detection (AUC 0.910).

Conclusions:

  • LVT remains a significant complication after STEMI, even with primary PCI.
  • Anterior STEMI location, specific ECG findings, echocardiographic abnormalities (WMSI, aneurysm, low EF) are independent predictors of LVT.
  • WMSI is a powerful tool for identifying patients at risk of LVT post-STEMI.